Merck Animal Health Receives the US FDA's Approval for Bravecto (fluralaner) Monthly Chews to Protect Dogs and Puppies Against Fleas and Ticks
Shots:
- The US FDA approves Bravecto 1-month (fluralaner) chews for dogs and puppies aged≥ 8 weeks. The approval will expand Merck’s parasiticide portfolio- which are extended duration flea and tick protection products offering parasite protection for dogs
- The product is suitable for dogs in the early stages of life to begin a regimen of monthly flea and tick protection
- Bravecto 1-month is administered as a single- monthly flavored chew formulation for treatment and prevention of fleas and treatment and control of ticks and is expected to be available in the coming months
Ref: Merck Animal Health | Image: Merck
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com